Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion.
In healthy monocytes, Toll-like receptor (TLR) engagement induces production of reactive oxygen species (ROS), followed by an antioxidant response involved in IL-1beta processing and secretion. Markers of the antioxidant response include intracellular thioredoxin and extracellular release of reduced cysteine. Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory diseases in which Nod-like receptor family pyrin domain-containing 3 (NLRP3) gene mutations lead to increased IL-1beta secretion. We show in a large cohort of patients that IL-1beta secretion by CAPS monocytes is much faster than that by healthy monocytes. This accelerated kinetics is caused by alterations in the basal redox state, as well as in the redox response to TLR triggering displayed by CAPS monocytes. Indeed, unstimulated CAPS monocytes are under a mild oxidative stress, with elevated levels of both ROS and antioxidants. The redox response to LPS is quickened, with early generation of the reducing conditions favoring IL-1beta processing and secretion, and then rapidly exhausted. Therefore, secretion of IL-1beta is accelerated, but reaches a plateau much earlier than in healthy controls. Pharmacologic inhibition of the redox response hinders IL-1beta release, confirming the functional link between redox impairment and altered kinetics of secretion. Monocytes from patients with juvenile idiopathic arthritis display normal kinetics of redox response and IL-1beta secretion, excluding a role of chronic inflammation in the alterations observed in CAPS. We conclude that preexisting redox alterations distinct from CAPS monocytes anticipate the pathogen-associated molecular pattern molecule-induced generation of the reducing environment favorable to inflammasome activation and IL-1beta secretion.
Tassi
Sara
S
Cell Biology Unit, National Cancer Research Institute, 16132 Genoa, Italy.
Carta
Sonia
S
Delfino
Laura
L
Caorsi
Roberta
R
Martini
Alberto
A
Gattorno
Marco
M
Rubartelli
Anna
A
D002478:Cells, Cultured; D056587:Cryopyrin-Associated Periodic Syndromes / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000276:immunology; D009000:Monocytes / Q000276:immunology / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress
D053583:Interleukin-1beta; D008070:Lipopolysaccharides
Eur J Immunol. 2008 Sep;38(9):2419-25
18792398
J Exp Med. 2005 May 2;201(9):1479-86
15851489
Nat Chem Biol. 2009 Oct;5(10):709-10
19763100
Arthritis Rheum. 2008 May;58(5):1505-15
18438814
J Exp Med. 1995 Sep 1;182(3):751-8
7650482
Blood. 2004 Apr 1;103(7):2809-15
14630794
Arthritis Rheum. 2007 Sep;56(9):3138-48
17763411
J Biol Chem. 2007 Feb 2;282(5):2871-9
17132626
Immunity. 2004 Mar;20(3):319-25
15030775
Blood. 2006 Mar 15;107(6):2501-6
16291594
Science. 2008 May 2;320(5876):674-7
18403674
Annu Rev Immunol. 2009;27:519-50
19302047
Blood. 2008 Feb 15;111(4):2132-41
18063752
N Engl J Med. 2006 Aug 10;355(6):581-92
16899778
Arthritis Rheum. 2002 Dec;46(12):3340-8
12483741
Annu Rev Immunol. 2009;27:229-65
19302040
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1491-6
11792859
J Neurosci. 2009 May 6;29(18):5910-5
19420257
J Leukoc Biol. 2009 Sep;86(3):549-55
19564570
J Immunol. 2008 Jun 15;180(12):8410-20
18523309
Antioxid Redox Signal. 2007 Jan;9(1):25-47
17115886
Brain Res. 2009 Jul 7;1279:99-108
19409882
J Biol Chem. 1999 Apr 23;274(17):11455-8
10206947
Arthritis Rheum. 2004 Oct;50(10):3329-33
15476236
Nat Immunol. 2008 Aug;9(8):866-72
18604212
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8067-72
18523012
Oncogene. 2008 Mar 6;27(11):1618-28
17828297
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11400-5
19549867
J Exp Med. 2009 May 11;206(5):1029-36
19364880
J Immunol. 2009 Jul 15;183(2):1456-62
19561107
Rheumatology (Oxford). 2007 Mar;46(3):473-8
16920754
Annu Rev Immunol. 2009;27:621-68
19302049
Methods. 2001 Dec;25(4):402-8
11846609